Regeneration Biomedical presents early Phase 1 trial data on Alzheimer's patients receiving stem cell therapy.
Regeneration Biomedical presents early data from Phase 1 clinical trial on Alzheimer's patients receiving stem cell therapy. Wnt-activated, autologous, expanded adipose-derived stem cells (RB-ADSCs) are administered directly into the lateral ventricles of the brain via Ommaya reservoir to bypass the blood-brain barrier. Data will be presented at the Alzheimer's Association International Conference on July 28, 2024.
July 28, 2024
3 Articles